Authors: Grossman, RI Rubin, DL Hunter, G Haughton, VM Lee, D Sze, G Kuhn, MJ Maravilla, K Tu, R Heindel, W Wippold, FJ Leeds, N Zelch, J Jinkins, JR Grodd, W Truwit, C Kanal, E Provenzale, JM Ramsey, R Simon, J Brunberg, JA Stevens, GR Kristy, RM

Citation: Ri. Grossman et al., Magnetic resonance imaging in patients with central nervous system pathology: A comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA), INV RADIOL, 35(7), 2000, pp. 412-419

Authors: Rubin, DL Desser, TS Semelka, R Brown, J Nghiem, HV Stevens, WR Bluemke, D Nelson, R Fultz, P Reimer, P Ho, V Kristy, RM Pierro, JA

Citation: Dl. Rubin et al., A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial, J MAGN R I, 9(2), 1999, pp. 240-250